49th Organic Process Research and Development Conference (OPR&D)

The efficient conversion of a chemical process into a process for manufacture on industrial scale is the central topic of the conference. The event offers opportunities for experts to network and share knowledge about current developments and future trends in chemical and pharmaceutical industry.

Who Should Attend

  • Process research and development chemists
  • Chemical engineers in industry
  • Heads of departments and team leaders

Selected Speakers

  • Brad D. Maxwell, Vertex Pharmaceuticals, USA
  • Diane Le, Merck, USA
  • Jean-Francois Vincent-Rocan, BioVectra, Canada
  • David Snead, Mirati Therapeutics, USA
  • Nima Yazdanpanah, Procegence, USA
  • Michael C. Haibach, AbbVie, USA
  • Johnny Lee, Pfizer, USA
  • Thomas Colacot, MilliporeSigma, USA
  • Jacob C. Timmerman, Genentech, USA
  • Andrew T. Parsons, Amgen, USA
  • Gregory Beutner, Bristol Myers Squibb, USA
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *